April 2001

Established in Kanda Jimbocho, Chiyoda-ku, Tokyo.

October 2002

Moved to Kanda in Chiyoda-ku, Tokyo.

January 2003

Started supporting the editing and production of guidelines in the ophthalmology field.
Supported "Viral Conjunctivitis Guidelines (2003)", "Contact Lens Practice Guidelines (2005)", "Allergic Conjunctivitis Guidelines (2006)", and "Infectious Keratitis Practice Guidelines (2007)".

April 2004

Received the "Nikkei Medical Award" at the 10th Nikkei BP Advertising Awards. The award-winning work was Takeda Pharmaceutical Company Limited's international strategic product "Blopress" (hypertension treatment drug)

April 2004

Moved to Nihonbashi Kabutocho, Chuo-ku, Tokyo.

April 2005

Received the "Nikkei Medical Award" for the second consecutive year at the 11th Nikkei BP Advertising Awards. The award-winning work was Takeda Pharmaceutical Company Limited's international strategic product "Blopress" (hypertension treatment drug)

December 2005

Selected as "Rising Company 2006" * by Teikoku Databank.
* Emerging growing company selected by Teikoku Databank from companies whose most recent annual sales have increased by 100 million yen or more and sales have increased by 10% or more for the second consecutive term within 10 years of establishment, and whose corporate income has been announced within the second term. This represents about 1% of the 170,000 target companies.

April 2006

Our website "Heart Failure.com" was introduced in the Nihon Keizai Shimbun "Yu & eye" and NIKKEI NET "Ikiiki Kenko".

May 2006

Received "Nikkei BP Award Best Advertising Award" at the 13th Nikkei BP Advertising Awards. The award-winning work was Takeda Pharmaceutical Company Limited's international strategic product "Blopress" (hypertension treatment drug)

June 2007

Business tie-up with overseas marketing company "Jam Japan Marketing".

September 2007

Held our seminar "Marketing Strategies and Success Stories of Pharmaceutical Companies in the United States and Latest Marketing Trends".

April 2008

Katsumi Kondo, our President and CEO, gave a lecture at the 5th PBA Pharmaceutical Marketing Academy. The theme was "The Road to Innovative Drug Promotion".

May 2008

Started operating as the Secretariat of the Japan Ophthalmology Allergy Study Group.

December 2009

Moved to Yaesu, Chuo-ku, Tokyo.

December 2016

Joined the M3 Group.

December 2016

Moved to Nihonbashihoncho, Chuo-ku, Tokyo.